Of the 542 seats in fray, BJP-led alliance NDA is leading in 321 seats, while Congress-led alliance UPA is leading in 94 seats, and in 92 seats Others are leading.

Overall volumes in futures & options currently stand at 72.91 lakhs contracts with a turnover of Rs. 5,27,886.13 crore.

Overall volumes in futures & options currently stand at 72.91 lakhs contracts with a turnover of Rs. 5,27,886.13 crore.

Nifty needs to decisively take out the level of 11,850 and, on the downside, support is seen around the Monday’s session low of 11,592. Going ahead, if bulls manage to defend the support level of 11,592 and the opening gap of May 20, it would be an interesting day’s ahead for the bulls. Stocks in news: L&T, Biocon, ITI, Bodal Chemicals, Wipro, OBC, HDFC Bank.

Today is the Judgement Day for the largest democracy in the world and the world will know who will be the 'king'. The markets are pricing in a clear victory for the NDA government and hence any deviation from this could lead to disappointment amongst the market participants. Volatility will be the buzzword in today’s session and the SEBI and the exchanges have stepped up their surveillance mechanisms. We might see a flat opening as indicated by SGX Nifty, however, as the day progresses, a roller-coaster ride could be seen.

Indore-based snack food company Prataap Snack said that the company is planning to launch a few more variants such as cupcakes, tiffin cakes in the near future, on Wednesday.

Plastic moulding company Sintex Plastics Technology announced that it plans to sell its Auto division, on Wednesday. The stock reacted positively to the development and gained 4 per cent.

The Gujarat-based tile maker, Asian Granito India Limited (AGIL), said that company has passed a circular resolution for divestment from its joint venture AGL Panaria Private limited.

Mutual funds can now diversify even further as they can invest in commodity futures via Exchange Traded Commodity Derivatives (ETCDs). Read on to find out more.

Budesonide Inhalation Suspension is used to control and avoid symptoms (wheezing and shortness of breath) caused by asthma. The said medicine had a projected market size of US$385.4 million in the 12-month period ending March 2019 in the US market.